Integrated Analysis of Single-Cell and Bulk RNA Sequencing Reveals HSD3B7 as a Prognostic Biomarker and Potential Therapeutic Target in ccRCC. Here, HSD3B7 is linked to nonpapillary renal cell carcinoma.